Oral glutamine protects against cyclophosphamide-induced cardiotoxicity in experimental rats through increase of cardiac glutathione

Valentina Todorova, Doug Vanderpool, Sarah Blossom, Emmanuel Nwokedi, Leah Hennings, Robert Mrak, Vicki Klimberg

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Objective: This study evaluated the effects of supplemental oral glutamine (GLN) on acute cardiotoxicity of cyclophosphamide (CPA) in experimental rats. The dose-related cardiotoxicity of CPA is associated with a rapid decrease in cardiac glutathione (GSH) and oxidative cardiac injury. GLN is a rate-limiting precursor for GSH synthesis during periods of oxidative and other types of stress when it becomes a conditionally essential amino acid. Methods: Forty-four male Fischer 344 rats were randomized into two groups to receive 1 g · kg-1 · d-1 of GLN or glycine by gavage. After 2 d of prefeeding, each of these groups was further randomized into three subgroups to receive intraperitoneally a lethal dose of CPA (450 mg/kg), a sublethal dose of CPA (200 mg/kg), or saline (controls). Twenty-four hours later all six groups of rats were sacrificed and blood GLN was measured. Cardiac tissue was examined for histopathologic alterations: GSH and oxidized GSH concentrations. Results: The results showed that dietary GLN decreased cardiac necrosis and maintained normal cardiac GSH levels. Elevated cardiac GSH levels in the GLN group correlated with increased arterial GLN levels. GLN protected against the acute cardiotoxic effects of CPA and significantly improved the short-term survival after lethal and sublethal doses of CPA. Conclusion: These data suggest that GLN may protect against CPA-related cardiac injury through maintenance of cardiac GSH metabolism.

Original languageEnglish (US)
Pages (from-to)812-817
Number of pages6
JournalNutrition
Volume25
Issue number7-8
DOIs
StatePublished - Jul 2009
Externally publishedYes

Fingerprint

Glutamine
Cyclophosphamide
Glutathione
Cardiotoxicity
Essential Amino Acids
Inbred F344 Rats
Wounds and Injuries
Glycine
Oxidative Stress
Necrosis
Maintenance

Keywords

  • Cardiotoxicity
  • Cyclophosphamide
  • Glutamine
  • Glutathione
  • Heart

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Nutrition and Dietetics

Cite this

Oral glutamine protects against cyclophosphamide-induced cardiotoxicity in experimental rats through increase of cardiac glutathione. / Todorova, Valentina; Vanderpool, Doug; Blossom, Sarah; Nwokedi, Emmanuel; Hennings, Leah; Mrak, Robert; Klimberg, Vicki.

In: Nutrition, Vol. 25, No. 7-8, 07.2009, p. 812-817.

Research output: Contribution to journalArticle

Todorova, Valentina ; Vanderpool, Doug ; Blossom, Sarah ; Nwokedi, Emmanuel ; Hennings, Leah ; Mrak, Robert ; Klimberg, Vicki. / Oral glutamine protects against cyclophosphamide-induced cardiotoxicity in experimental rats through increase of cardiac glutathione. In: Nutrition. 2009 ; Vol. 25, No. 7-8. pp. 812-817.
@article{33d4ce09c73d4e81b016f162b7a82034,
title = "Oral glutamine protects against cyclophosphamide-induced cardiotoxicity in experimental rats through increase of cardiac glutathione",
abstract = "Objective: This study evaluated the effects of supplemental oral glutamine (GLN) on acute cardiotoxicity of cyclophosphamide (CPA) in experimental rats. The dose-related cardiotoxicity of CPA is associated with a rapid decrease in cardiac glutathione (GSH) and oxidative cardiac injury. GLN is a rate-limiting precursor for GSH synthesis during periods of oxidative and other types of stress when it becomes a conditionally essential amino acid. Methods: Forty-four male Fischer 344 rats were randomized into two groups to receive 1 g · kg-1 · d-1 of GLN or glycine by gavage. After 2 d of prefeeding, each of these groups was further randomized into three subgroups to receive intraperitoneally a lethal dose of CPA (450 mg/kg), a sublethal dose of CPA (200 mg/kg), or saline (controls). Twenty-four hours later all six groups of rats were sacrificed and blood GLN was measured. Cardiac tissue was examined for histopathologic alterations: GSH and oxidized GSH concentrations. Results: The results showed that dietary GLN decreased cardiac necrosis and maintained normal cardiac GSH levels. Elevated cardiac GSH levels in the GLN group correlated with increased arterial GLN levels. GLN protected against the acute cardiotoxic effects of CPA and significantly improved the short-term survival after lethal and sublethal doses of CPA. Conclusion: These data suggest that GLN may protect against CPA-related cardiac injury through maintenance of cardiac GSH metabolism.",
keywords = "Cardiotoxicity, Cyclophosphamide, Glutamine, Glutathione, Heart",
author = "Valentina Todorova and Doug Vanderpool and Sarah Blossom and Emmanuel Nwokedi and Leah Hennings and Robert Mrak and Vicki Klimberg",
year = "2009",
month = "7",
doi = "10.1016/j.nut.2009.01.004",
language = "English (US)",
volume = "25",
pages = "812--817",
journal = "Nutrition International",
issn = "0899-9007",
publisher = "Elsevier Inc.",
number = "7-8",

}

TY - JOUR

T1 - Oral glutamine protects against cyclophosphamide-induced cardiotoxicity in experimental rats through increase of cardiac glutathione

AU - Todorova, Valentina

AU - Vanderpool, Doug

AU - Blossom, Sarah

AU - Nwokedi, Emmanuel

AU - Hennings, Leah

AU - Mrak, Robert

AU - Klimberg, Vicki

PY - 2009/7

Y1 - 2009/7

N2 - Objective: This study evaluated the effects of supplemental oral glutamine (GLN) on acute cardiotoxicity of cyclophosphamide (CPA) in experimental rats. The dose-related cardiotoxicity of CPA is associated with a rapid decrease in cardiac glutathione (GSH) and oxidative cardiac injury. GLN is a rate-limiting precursor for GSH synthesis during periods of oxidative and other types of stress when it becomes a conditionally essential amino acid. Methods: Forty-four male Fischer 344 rats were randomized into two groups to receive 1 g · kg-1 · d-1 of GLN or glycine by gavage. After 2 d of prefeeding, each of these groups was further randomized into three subgroups to receive intraperitoneally a lethal dose of CPA (450 mg/kg), a sublethal dose of CPA (200 mg/kg), or saline (controls). Twenty-four hours later all six groups of rats were sacrificed and blood GLN was measured. Cardiac tissue was examined for histopathologic alterations: GSH and oxidized GSH concentrations. Results: The results showed that dietary GLN decreased cardiac necrosis and maintained normal cardiac GSH levels. Elevated cardiac GSH levels in the GLN group correlated with increased arterial GLN levels. GLN protected against the acute cardiotoxic effects of CPA and significantly improved the short-term survival after lethal and sublethal doses of CPA. Conclusion: These data suggest that GLN may protect against CPA-related cardiac injury through maintenance of cardiac GSH metabolism.

AB - Objective: This study evaluated the effects of supplemental oral glutamine (GLN) on acute cardiotoxicity of cyclophosphamide (CPA) in experimental rats. The dose-related cardiotoxicity of CPA is associated with a rapid decrease in cardiac glutathione (GSH) and oxidative cardiac injury. GLN is a rate-limiting precursor for GSH synthesis during periods of oxidative and other types of stress when it becomes a conditionally essential amino acid. Methods: Forty-four male Fischer 344 rats were randomized into two groups to receive 1 g · kg-1 · d-1 of GLN or glycine by gavage. After 2 d of prefeeding, each of these groups was further randomized into three subgroups to receive intraperitoneally a lethal dose of CPA (450 mg/kg), a sublethal dose of CPA (200 mg/kg), or saline (controls). Twenty-four hours later all six groups of rats were sacrificed and blood GLN was measured. Cardiac tissue was examined for histopathologic alterations: GSH and oxidized GSH concentrations. Results: The results showed that dietary GLN decreased cardiac necrosis and maintained normal cardiac GSH levels. Elevated cardiac GSH levels in the GLN group correlated with increased arterial GLN levels. GLN protected against the acute cardiotoxic effects of CPA and significantly improved the short-term survival after lethal and sublethal doses of CPA. Conclusion: These data suggest that GLN may protect against CPA-related cardiac injury through maintenance of cardiac GSH metabolism.

KW - Cardiotoxicity

KW - Cyclophosphamide

KW - Glutamine

KW - Glutathione

KW - Heart

UR - http://www.scopus.com/inward/record.url?scp=67349280855&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67349280855&partnerID=8YFLogxK

U2 - 10.1016/j.nut.2009.01.004

DO - 10.1016/j.nut.2009.01.004

M3 - Article

VL - 25

SP - 812

EP - 817

JO - Nutrition International

JF - Nutrition International

SN - 0899-9007

IS - 7-8

ER -